These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10597234)

  • 1. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
    Rao RN; Stamm NB; Otto K; Kovacevic S; Watkins SA; Rutherford P; Lemke S; Cocke K; Beckmann RP; Houck K; Johnson D; Skidmore BJ
    Oncogene; 1999 Nov; 18(46):6343-56. PubMed ID: 10597234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
    Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
    Chen Q; Lin J; Jinno S; Okayama H
    Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
    Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A; Miturski R; Skomra D; Jakowicki JA
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell cycle alterations of human embryo lung fibroblasts induced by benzo(a)pyrene is positively regulated by cyclin D1 and CDK4].
    Du H; Liu B; Tang N; Shi X
    Wei Sheng Yan Jiu; 2008 Jul; 37(4):393-6. PubMed ID: 18839518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4.
    Haas K; Johannes C; Geisen C; Schmidt T; Karsunky H; Blass-Kampmann S; Obe G; Möröy T
    Oncogene; 1997 Nov; 15(21):2615-23. PubMed ID: 9399649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
    Dierov J; Prosniak M; Gallia G; Gartenhaus RB
    J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis.
    Lazarov M; Kubo Y; Cai T; Dajee M; Tarutani M; Lin Q; Fang M; Tao S; Green CL; Khavari PA
    Nat Med; 2002 Oct; 8(10):1105-14. PubMed ID: 12357246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
    Villalonga P; Rius E; Bachs O; Agell N
    Oncogene; 2000 Feb; 19(5):690-9. PubMed ID: 10698514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.
    Zwicker J; Brüsselbach S; Jooss KU; Sewing A; Behn M; Lucibello FC; Müller R
    Oncogene; 1999 Jan; 18(1):19-25. PubMed ID: 9926916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
    Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
    J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
    Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M
    Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
    Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
    Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
    Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.